09:27 AM EST - Oncolytics Biotech Inc : Today announced that Dr. Matt Coffey, President and Chief Executive Officer, will participate in the Novel Mechanisms with Important Readouts panel at Cantor Fitzgerald's The Future of Oncology Virtual Symposium, which is taking place April 3-5, 2023 in a virtual format. Additional details on the panel presentation can be found below. Oncolytics Biotech Inc
shares T.ONC are trading up $0.02 at $1.69.
